Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Conditions
- Pneumococcal Immunisation
- Diphtheria Immunisation
- Tetanus Immunisation
- Pertussis Immunisation
- Hepatitis B Immunisation
- Haemophilus Influenzae Type b Immunisation
- Polio Immunisation
- Measles Immunisation
- Rubella Immunisation
- Varicella Immunisation
- Mumps Immunisation
Interventions
- BIOLOGICAL: Pneumococcal Conjugate Vaccine formulation 1
- BIOLOGICAL: Pneumococcal Conjugate Vaccine formulation 2
- BIOLOGICAL: Pneumococcal Conjugate Vaccine formulation 3
- BIOLOGICAL: Varicella Virus Vaccine Live
- BIOLOGICAL: Measles, Mumps, and Rubella Virus Vaccine Live
- BIOLOGICAL: Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]
- BIOLOGICAL: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)
- BIOLOGICAL: Rotavirus Vaccine, Live, Oral, Pentavalent
- BIOLOGICAL: Hepatitis B Vaccine* [Recombinant] *as applicable
Sponsor
Sanofi Pasteur, a Sanofi Company